A 734-case cohort study from the GTE (Groupe d'étude des Tumeurs Endocrines).
暂无分享,去创建一个
A. Tabarin | P. Ruszniewski | P. Niccoli | F. Borson‐Chazot | G. Chabrier | F. Menegaux | A. Murat | P. Goudet | C. Bonithon‐Kopp
[1] Alberto Fernández,et al. Prevalence of pituitary adenomas: a community‐based, cross‐sectional study in Banbury (Oxfordshire, UK) , 2010, Clinical endocrinology.
[2] R. Thakker,et al. Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1) , 2010, Human mutation.
[3] A. Tabarin,et al. Risk Factors and Causes of Death in MEN1 Disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) Cohort Study Among 758 Patients , 2010, World Journal of Surgery.
[4] M. Brandi,et al. Multiple endocrine neoplasia type I variants and phenocopies: more than a nosological issue? , 2009, The Journal of clinical endocrinology and metabolism.
[5] A. Tabarin,et al. Thymic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: A Comparative Study on 21 Cases Among a Series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines) , 2009, World Journal of Surgery.
[6] G. Doherty,et al. Multiple endocrine neoplasia. , 2008, Surgical oncology clinics of North America.
[7] M. Rothmund,et al. Age‐related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers , 2007, Clinical endocrinology.
[8] L. Niskanen,et al. Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation. , 2007, European journal of endocrinology.
[9] M. Höfler,et al. Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1. , 2007, Experimental and clinical endocrinology & diabetes.
[10] K. Mulder,et al. Menin links estrogen receptor activation to histone H3K4 trimethylation. , 2006, Cancer research.
[11] M. Imamura,et al. Multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas in Japan. , 2005, Oncology reports.
[12] M. Brandi,et al. Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. , 2005, The Journal of clinical endocrinology and metabolism.
[13] B. Schaller. Gender-related differences in prolactinomas. A clinicopathological study. , 2005, Neuro endocrinology letters.
[14] T. Kameya,et al. Recent advances in MEN1 gene study for pituitary tumor pathogenesis. , 2004, Frontiers of hormone research.
[15] G. Thiéfin,et al. Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry. , 2004, Gastroenterologie clinique et biologique.
[16] L. Hunyady,et al. Genetic screening methods for the detection of mutations responsible for multiple endocrine neoplasia type 1. , 2004, Molecular genetics and metabolism.
[17] R. Jensen,et al. Multiple Endocrine Neoplasia Type 1 and Zollinger-Ellison Syndrome: A Prospective Study of 107 Cases and Comparison With 1009 Cases From the Literature , 2004, Medicine.
[18] A. Vortmeyer,et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. , 2003, The Journal of clinical endocrinology and metabolism.
[19] A. Gozzini,et al. Multiple endocrine neoplasia type 1 , 2006, Reviews in endocrine & metabolic disorders.
[20] A. Vortmeyer,et al. Identical clonality of sporadic gastrinomas at multiple sites. , 2000, Cancer research.
[21] A. Beckers,et al. Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis. , 1999, European journal of endocrinology.
[22] P. Ruszniewski,et al. Prognostic Factors in Patients With Zollinger-Ellison Syndrome and Multiple Endocrine Neoplasia Type 1 , 1999 .
[23] P. Chanson,et al. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. , 1998, American journal of human genetics.
[24] C. Larsson,et al. Thymic carcinoids in multiple endocrine neoplasia type 1. , 1998, Journal of internal medicine.
[25] Mignon,et al. Diagnostic and therapeutic criteria in patients with Zollinger–Ellison syndrome and multiple endocrine neoplasia type 1 , 1998, Journal of internal medicine.
[26] Y Wang,et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. , 1997, Science.
[27] C. Edwards,et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN1) , 1996, QJM : monthly journal of the Association of Physicians.
[28] G. Faglia. Epidemiology and pathogenesis of pituitary adenomas. , 1993, Acta endocrinologica.
[29] J. Shepherd. The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized? , 1991, Archives of surgery.
[30] J. Norton,et al. Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study. , 1987, Surgery.
[31] J. V. van Heerden,et al. Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type I. , 1986, Surgery.